Researchers at the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital, and Houston Methodist Hospital have developed a chimeric antigen receptor (CAR) T-cell therapy targeting T-cell lymphoma, an aggressive and difficult-to-treat cancer.

from Medical Xpress - latest medical and health news stories https://ift.tt/opYJG71